Andrew Obenshain is President and CEO of bluebird bio, Inc.. Currently has a direct ownership of 374,247 shares of BLUE, which is worth approximately $3.44 Million. The most recent transaction as insider was on Feb 02, 2021, when has been sold 34 shares (Common Stock) at a price of $45.93 per share, resulting in proceeds of $1,562. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 374K
0.26% 3M change
29.96% 12M change
Total Value Held $3.44 Million

Andrew Obenshain Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 02 2021
SELL
Open market or private sale
$1,562 $45.93 p/Share
34 Reduced 0.14%
23,884 Common Stock
AO

Andrew Obenshain

President and CEO
Somerville, MA

Track Institutional and Insider Activities on BLUE

Follow bluebird bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLUE shares.

Notify only if

Insider Trading

Get notified when an Bluebird Bio, Inc. insider buys or sells BLUE shares.

Notify only if

News

Receive news related to bluebird bio, Inc.

Track Activities on BLUE